Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites

다국어 초록 (Multilingual Abstract)

Purpose: Follistatin-like protein 1 (FSTL1) is a secreted glycoprotein that has been shown to play a role in various types of cancer.
However, the clinical significance and function of FSTL1 in breast cancer have not been reported. We investigated the role of FSTL1 in breast cancer in this study. Methods: Enzyme-linked immunosorbent assays, western blot analysis, and reverse transcription polymerase chain reaction were used to monitor the expression of FSTL1 in breast cancer tissue and in serum samples from breast cancer patients. We employed a 4T1 breast cancer model and Fstl1+/− mice for in vivo studies. Hematoxylin and eosin staining, western blot analysis, and RNA sequencing were used to analyze the effect of FSTL1 on primary tumor growth and lung metastasis. Results: We demonstrated that the expression of FSTL1 is reduced in both the breast cancer tissue and the serum of breast cancer patients. We showed that reduced levels of FSTL1 in serum correlate with elevated expression of Ki-67 and epidermal growth factor receptor (EGFR) in cancer tissues. Moreover, lowered expression of FSTL1 was associated with decreased survival in breast cancer patients. Experiments on the Fstl1+/− mouse model established that FSTL1 deficiency had no effect on primary tumor growth, but increased the lung metastases of breast cancer cells, resulting in reduced survival of tumor-bearing mice. RNA sequencing found significantly reduced expression of Egln3 and increased expression of EGFR in Fstl1+/− mice. Thus, our results suggest that FSTL1 may affect the expression of EGFR through Egln3, inhibiting the proliferation of breast cancer cells at lung metastatic sites. Conclusion: In conclusion, we suggest a suppressor role of FSTL1 in breast cancer lung metastasis. Furthermore, FSTL1 may represent a potential prognostic biomarker and a candidate therapeutic target in breast cancer patients.

참고문헌 (Reference)

1 Su S, "Up-regulation of follistatin-like 1 by the androgen receptor and melanoma antigen-a11 in prostate cancer" 77 : 505-516, 2017

2 Chan QK, "Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis" 30 : 114-121, 2009

3 Rakha EA, "Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes" 15 : 2302-2310, 2009

4 Hatzimichael E, "The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia" 84 : 47-51, 2010

5 Zhao W, "Suppression of lung cancer cell invasion and metastasis by connexin43 involves the secretion of follistatin-like 1 mediated via histone acetylation" 43 : 1459-1468, 2011

6 Xue J, "Prolyl hydroxylase-3 is downregulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity" 138 : 606-615, 2010

7 Su Y, "PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer" 103 : 1571-1579, 2010

8 Garvalov BK, "PHD3 regulates EGFR internalization and signalling in tumours" 5 : 5577-, 2014

9 Reddy SP, "Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis" 14 : 2978-2987, 2008

10 Miyabe M, "Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury" 103 : 111-120, 2014

11 Gao H, "Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 signaling" 166 : 47-62, 2016

12 Peddi PF, "Molecular basis of triple negative breast cancer and implications for therapy" 2012 : 217185-, 2012

13 Bae K, "Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cells" 7 : 18076-18084, 2016

14 Dong-liang Shi, "MicroRNA-27a Inhibits Cell Migration and Invasion of Fibroblast-Like Synoviocytes by Targeting Follistatin-Like Protein 1 in Rheumatoid Arthritis" 한국분자세포생물학회 39 (39): 611-618, 2016

15 Henze AT, "Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR" 5 : 5582-, 2014

16 Trojan L, "Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines" 25 (25): 183-191, 2005

17 Lehmann BD, "Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies" 121 : 2750-2767, 2011

18 Tsou PS, "Histone deacetylase 5 is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors" 68 : 2975-2985, 2016

19 Hodgson G, "Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas" 29 : 459-464, 2001

20 Li D, "Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis" 13 : R17-, 2011

21 Oshima Y, "Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart" 117 : 3099-3108, 2008

22 Geng Y, "Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development" 108 : 7058-7063, 2011

23 Lau MC, "FSTL1 promotes metastasis and chemoresistance in esophageal squamous cell carcinoma through $NF{\kappa}B$-BMP signaling cross-talk" 77 : 5886-5899, 2017

24 Witton CJ, "Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer" 200 : 290-297, 2003

25 Zhou X, "Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma" 7 : 16433-16444, 2016

26 An J, "Effects of FSTL1 on cell proliferation in breast cancer cell line MDA MB 231 and its brain metastatic variant MDA MB 231 BR" 38 : 3001-3010, 2017

27 Shibanuma M, "Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide" 217 : 13-19, 1993

28 Meng X, "An activated sympathetic nervous system affects white adipocyte differentiation and lipolysis in a rat model of Parkinson's disease" 93 : 350-360, 2015

29 Li J, "A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China" 11 : 364-, 2011

30 Liu Y, "A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expression" 6 : 26689-, 2016